APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,889,286 | -60.2% | 102,242 | -4.6% | 0.05% | -46.5% |
| Q2 2023 | $9,759,999 | +6.8% | 107,135 | -22.7% | 0.09% | -3.4% |
| Q1 2023 | $9,142,188 | +11.2% | 138,602 | -12.8% | 0.09% | +3.5% |
| Q4 2022 | $8,218,012 | -99.9% | 158,925 | -5.9% | 0.09% | -31.7% |
| Q3 2022 | $11,540,719,000 | +142044.6% | 168,971 | -5.9% | 0.13% | +57.5% |
| Q2 2022 | $8,119,000 | -15.6% | 179,550 | -5.1% | 0.08% | +8.1% |
| Q1 2022 | $9,614,000 | -39.7% | 189,223 | -43.8% | 0.07% | +25.4% |
| Q4 2021 | $15,932,000 | +2765.5% | 336,978 | +1896.0% | 0.06% | +883.3% |
| Q3 2021 | $556,000 | -61.1% | 16,883 | -25.4% | 0.01% | -62.5% |
| Q2 2021 | $1,430,000 | +54.4% | 22,625 | +4.9% | 0.02% | +33.3% |
| Q1 2021 | $926,000 | – | 21,578 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |